Success Metrics

Clinical Success Rate
96.9%

Based on 123 completed trials

Completion Rate
97%(123/127)
Active Trials
0(0%)
Results Posted
58%(71 trials)
Terminated
4(3%)

Phase Distribution

Ph phase_1
13
10%
Ph phase_2
18
13%
Ph phase_3
50
37%
Ph phase_4
38
28%
Ph early_phase_1
1
1%
Ph not_applicable
3
2%

Phase Distribution

14

Early Stage

18

Mid Stage

88

Late Stage

Phase Distribution123 total trials
Early Phase 1First-in-human
1(0.8%)
Phase 1Safety & dosage
13(10.6%)
Phase 2Efficacy & side effects
18(14.6%)
Phase 3Large-scale testing
50(40.7%)
Phase 4Post-market surveillance
38(30.9%)
N/ANon-phased studies
3(2.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.6%

123 of 130 finished

Non-Completion Rate

5.4%

7 ended early

Currently Active

0

trials recruiting

Total Trials

134

all time

Status Distribution
Completed(123)
Terminated(7)
Other(4)

Detailed Status

Completed123
Terminated4
Withdrawn3
unknown3
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
134
Active
0
Success Rate
96.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.8%)
Phase 113 (10.6%)
Phase 218 (14.6%)
Phase 350 (40.7%)
Phase 438 (30.9%)
N/A3 (2.4%)

Trials by Status

withdrawn32%
completed12392%
suspended11%
unknown32%
terminated43%

Recent Activity

Clinical Trials (134)

Showing 20 of 134 trialsScroll for more
NCT07541378Not Applicable

Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD

Suspended
NCT03246581Phase 1

Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

Completed
NCT05506865Phase 4

Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure

Completed
NCT05165485Phase 4

Phase 4 COPD and Suboptimal Inspiratory Flow Rate

Completed
NCT02627625Phase 1

Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products

Completed
NCT03302065Phase 1

Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference

Completed
NCT02676297Phase 1

Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products

Completed
NCT06525051

Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease

Completed
NCT05501639

Exacerbation Risk in Asthma

Completed
NCT00239447Phase 3

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD

Completed
NCT00388882Phase 4

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Completed
NCT00274560Phase 3

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Completed
NCT00668772Phase 3

Tiotropium/Salmeterol Inhalation Powder in COPD

Terminated
NCT05179512

Replication of the INSPIRE Trial in Healthcare Claims Data

Completed
NCT05083429

Replication of the POET-COPD Trial in Healthcare Claims Data

Completed
NCT04249310

Early Intervention Efficacy in COPD

Completed
NCT02518139Phase 3

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT01176903Phase 1

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Completed
NCT01911364Phase 3

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

Completed
NCT02872090Phase 4

Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
134